Appropriateness of Empirical Fluoroquinolones Therapy in Patients Infected with Escherichia coli, Klebsiella pneumoniae, or Pseudomonas aeruginosa: The Importance of the CLSI Breakpoints Revision

Wang Y, Zhang X, Wang X, Lai X

Infection and Drug Resistance 2021, 14:3541-3552

Published Date: 31 August 2021